Literature DB >> 25127358

The prevalence of abnormal genital findings, vulvovaginitis, enuresis and encopresis in children who present with allegations of sexual abuse.

B Anderson1, I Thimmesch2, N Aardsma3, M Terrell Ed D4, S Carstater5, J Schober6.   

Abstract

OBJECTIVE: To assess the prevalence of vulvovaginitis, enuresis and encopresis in children who were referred for allegations of sexual abuse.
SUBJECTS: A retrospective chart review of 1280 children presenting for non-acute examination after allegations of sexual abuse during a 15-year time span. Interview documentation, physical examination documentation, urinalysis, urine and vaginal cultures were reviewed.
RESULTS: Of the 1280 children, 73.3% were female and 26.7% male. The ages of the children ranged from 6 months to 18 years (median age was 6 years). Interviews revealed that fondling contact was the most common allegation, followed by oral, vaginal, and anal penetration. Interviews also disclosed lower urinary tract symptoms, UTI, constipation, encopresis and enuresis. Physical examination revealed no abnormal genital findings in 44.7% of cases. Examinations of the vagina noted: erythema (18.1%); hymenal notching (posterior 16.8%, anterior 4.4%); vuvlovaginitis (14.0%); laceration or transection (0.6%); and bruising (0.4%). Examination of the anus noted: anal fissure/tear (14.9%); loss of anal tone (10.6%); reflex anal dilatation (9.2%); venous congestion (3.8%); and proctitis (0.9%). Vulvovaginitis was noted in 14% (131/936) and encopresis in 2.3% (21/936). Enuresis according to age was reported in 13% of 5-9 year olds, 14.7% of 10-16 year olds and 18.2% of 17-18 year olds suspected of being abused.
CONCLUSION: Prevalence of vulvovaginitis and enuresis were increased, and encopresis was decreased in children with allegations of sexual abuse when compared to the general pediatric population. Physicians should continue to be aware of the possibility of the presence of these conditions in children who have been sexually abused, and offer appropriate treatment.
Copyright © 2014 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Child abuse; Elimination disorders; Enuresis; Pediatrics; Sexual; Vaginitis

Mesh:

Year:  2014        PMID: 25127358     DOI: 10.1016/j.jpurol.2014.06.011

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  6 in total

Review 1.  Clinical presentation, diagnosis and treatment of vulvovaginitis in girls: a current approach and review of the literature.

Authors:  İlke Beyitler; Salih Kavukcu
Journal:  World J Pediatr       Date:  2016-12-15       Impact factor: 2.764

2.  Prevalence of suspected child abuse in children with constipation: a case-control study.

Authors:  Mana H Vriesman; Thekla F Vrolijk-Bosschaart; Ramón J L Lindauer; Johanna H van der Lee; Sonja Brilleslijper-Kater; Arianne H Teeuw; Marc A Benninga
Journal:  BMJ Paediatr Open       Date:  2022-02

Review 3.  Urogenital tract disorders in children suspected of being sexually abused.

Authors:  Wojciech Krajewski; Joanna Wojciechowska; Maja Krefft; Lidia Hirnle; Anna Kołodziej
Journal:  Cent European J Urol       Date:  2016-03-21

Review 4.  Child modern slavery, trafficking and health: a practical review of factors contributing to children's vulnerability and the potential impacts of severe exploitation on health.

Authors:  Laura C N Wood
Journal:  BMJ Paediatr Open       Date:  2020-06-01

5.  Clinical practice: recognizing child sexual abuse-what makes it so difficult?

Authors:  Thekla F Vrolijk-Bosschaart; Sonja N Brilleslijper-Kater; Marc A Benninga; Ramón J L Lindauer; Arianne H Teeuw
Journal:  Eur J Pediatr       Date:  2018-06-25       Impact factor: 3.183

6.  Perceptions of Peer Support for Victim-Survivors of Sexual Violence and Abuse: An Exploratory Study With Key Stakeholders.

Authors:  Alison Gregory; Emma Johnson; Gene Feder; John Campbell; Judit Konya; Concetta Perôt
Journal:  J Interpers Violence       Date:  2021-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.